Indoco Remedies Limited has announced that it has received final approval from the USFDA for its generic version of Cetirizine Hydrochloride Tablets USP, 10 mg. This over-the-counter medication is a generic equivalent of Zyrtec Allergy Tablets, 10 mg, originally by Johnson & Johnson Consumer Inc. The tablets, used to relieve symptoms of hay fever and other allergic conditions, will be manufactured at Indoco’s facility in Goa, India.
Commenting on this development, Ms. Aditi Panandikar, Managing Director of Indoco Remedies, highlighted the company’s commitment to providing high-quality, affordable healthcare solutions globally. She added that this approval represents a significant step for the company in expanding its OTC product portfolio.
Indoco Remedies, a research-oriented pharmaceutical company, operates 11 manufacturing facilities and has a strong global presence. With a turnover of USD 212 million, the company employs over 6,000 people, including more than 400 skilled scientists. Its product range covers various therapeutic segments, including Gastro-intestinal, Respiratory, Anti-Infective, and Cardiovascular, among others. Indoco also has partnerships with major generic companies worldwide.
